Commodore Capital’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,954,970
| Closed | -$2.19M | – | 27 |
|
|
2022
Q1 | $2.19M | Hold |
1,954,970
| – | – | 0.49% | 27 |
|
|
2021
Q4 | $3.13M | Sell |
1,954,970
-17,988
| -0.9% | -$28.8K | 0.72% | 23 |
|
|
2021
Q3 | $4.78M | Sell |
1,972,958
-86,771
| -4% | -$210K | 1.26% | 24 |
|
|
2021
Q2 | $6.53M | Buy |
2,059,729
+10,972
| +0.5% | +$34.8K | 2.27% | 18 |
|
|
2021
Q1 | $6.9M | Buy |
2,048,757
+194,479
| +10% | +$655K | 2.75% | 17 |
|
|
2020
Q4 | $6.64M | Buy |
+1,854,278
| New | +$6.64M | 3.61% | 14 |
|